Litigation

Recent Posts

5th Circuit: Mensing Doesn't Make Brand-Name Defendants Liable For Injuries
Posted on 26 Oct 2012 by Tom Moylan

NEW ORLEANS - (Mealey's) The U.S. Supreme Court's ruling that preempts failure-to-warn claims involving generic drugs does not change Louisiana state law and make manufacturers of brand-name versions liable, a Fifth Circuit U.S. Court of Appeals... Read More

Tags: Julie Demahy v. Schwarz Pharma , preemption , failure-to-warn claims , Wyeth Inc. , Parkinson's disease. , tardive dyskinesia , Actavis Inc. , Mensing , Schwarz Pharma Inc. , Litigation , Inc. v. Mensing , Pliva , generic drugs , Fifth Circuit , Louisiana state law , metoclopramide , Reglan , Julie Demahy , U.S. Supreme Court

Carella Byrne Files Securities Class Action Lawsuit Against Wyeth
Posted on 2 Jul 2010 by LexisNexis Litigation Resource Community Staff

ROSELAND, N.J. - Carella, Byrne, Cecchi, Olstein, Brody & Agnello P.C. on June 29 announced that a securities class action lawsuit was filed on June 18 in the U.S. District Court for the District of New Jersey on behalf of purchasers of Wyeth Inc... Read More

Tags: Security Police and Fire Professionals of America Retirement Fund v. Pfizer Inc. , Greg Norden , Bernard Poussot , Carella Byrne Cecchi Olstein Brody & Agnello P.C. , Wyeth Inc. , Pfizer Inc. , Wyeth Research , new lawsuit filings , Securities Exchange Act of 1934 , class action , Litigation , lawsuit , Robert R. Ruffolo Jr. , Robert Essner , Kenneth J. Martin , Securities